Diaceutics (DXRX) Competitors

Diaceutics (LON:DXRX) and ANGLE (LON:AGL) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, media sentiment, analyst recommendations, dividends, community ranking, valuation, risk, institutional ownership and earnings.

Do institutionals and insiders believe in DXRX or AGL?

51.1% of Diaceutics shares are held by institutional investors. Comparatively, 27.5% of ANGLE shares are held by institutional investors. 36.3% of Diaceutics shares are held by insiders. Comparatively, 10.7% of ANGLE shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Which has more volatility and risk, DXRX or AGL?

Diaceutics has a beta of 0.42, meaning that its stock price is 58% less volatile than the S&P 500. Comparatively, ANGLE has a beta of 0.2, meaning that its stock price is 80% less volatile than the S&P 500.

Does the MarketBeat Community believe in DXRX or AGL?

ANGLE received 171 more outperform votes than Diaceutics when rated by MarketBeat users. However, 81.82% of users gave Diaceutics an outperform vote while only 62.07% of users gave ANGLE an outperform vote.

Company	Underperform	Outperform
Diaceutics	Outperform Votes 9 81.82%	Underperform Votes 2 18.18%
ANGLE	Outperform Votes 180 62.07%	Underperform Votes 110 37.93%

Does the media favor DXRX or AGL?

In the previous week, ANGLE's average media sentiment score of 0.18 beat Diaceutics' score of 0.00 indicating that ANGLE is being referred to more favorably in the news media.

Company	Overall Sentiment
Diaceutics	Neutral
ANGLE	Neutral

Do analysts rate DXRX or AGL?

Diaceutics currently has a consensus target price of GBX 150, suggesting a potential upside of 44.23%. ANGLE has a consensus target price of GBX 120, suggesting a potential upside of 879.59%. Given ANGLE's higher probable upside, analysts clearly believe ANGLE is more favorable than Diaceutics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Diaceutics	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
ANGLE	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Which has higher earnings and valuation, DXRX or AGL?

Diaceutics has higher revenue and earnings than ANGLE.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Diaceutics	£21.90M	4.02	N/A	N/A	N/A
ANGLE	£1.82M	17.54	-£22.28M	-£0.09	-136.11

Is DXRX or AGL more profitable?

Diaceutics has a net margin of 0.03% compared to ANGLE's net margin of 0.00%. Diaceutics' return on equity of 0.01% beat ANGLE's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Diaceutics	0.03%	0.01%	-0.72%
ANGLE	N/A	-69.68%	-38.07%

Summary

Diaceutics beats ANGLE on 10 of the 14 factors compared between the two stocks.